Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Calcium signaling pathway | R-HSA-381753 | map04020 | isoniazid | 3718 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | isoniazid | 3718 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | isoniazid | 3718 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | isoniazid | 3718 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | isoniazid | 3718 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | isoniazid | 3718 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | isoniazid | 3718 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | isoniazid | 3718 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | isoniazid | 3718 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | isoniazid | 3718 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | isoniazid | 3718 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | isoniazid | 3718 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | isoniazid | 3718 | drug-path |
| Basal cell carcinoma | R-HSA-5626181 | map05217 | isoniazid | 3718 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | tranexamic acid | 2966 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ampyrone | 2151 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ampyrone | 2151 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ampyrone | 2151 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | ampyrone | 2151 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | midodrine | 4195 | drug-path |